Received Jul 1, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
went through a round of Paxlovid; went through a round of Paxlovid; This is a spontaneous report received from a Consumer or other non HCP, Program ID. A 68-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), in Oct2024 as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Comirnaty (DOSE 1), for COVID-19 immunization; Comirnaty (DOSE 2), for COVID-19 immunization; Comirnaty (DOSE NUMBER UNKNOWN (BOOSTER)), for COVID-19 immunization. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jun2025, outcome "recovering" and all described as "went through a round of Paxlovid". The clinical course was reported as follows: The patient's wife mentioned herself, her husband and son, had all Pfizer vaccines and updates, last vaccination occurred on Oct2024. The patient got sick with COVID, and he went through a round of Paxlovid. The patient's prescription was filled on 16Jun2025. It was reported the patient felt better and was able to return to work. Therapeutic measures were taken as a result of vaccination failure, covid-19.